3 LEAD EXTENSION WITH 2 INTERLINK INJECTION SITES

Set, Administration, Intravascular

BAXTER HEALTHCARE CORP.

The following data is part of a premarket notification filed by Baxter Healthcare Corp. with the FDA for 3 Lead Extension With 2 Interlink Injection Sites.

Pre-market Notification Details

Device IDK915390
510k NumberK915390
Device Name:3 LEAD EXTENSION WITH 2 INTERLINK INJECTION SITES
ClassificationSet, Administration, Intravascular
Applicant BAXTER HEALTHCARE CORP. ROUTE 120 AND WILSON RD. Round Lake,  IL  60073
ContactMarcia Marconi
CorrespondentMarcia Marconi
BAXTER HEALTHCARE CORP. ROUTE 120 AND WILSON RD. Round Lake,  IL  60073
Product CodeFPA  
CFR Regulation Number880.5440 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1991-11-29
Decision Date1992-03-12

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
20085412004765 K915390 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.